Multimeric-001 (M-001)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Multimeric-001 (M-001), covering 2020-02-05 to 2020-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine [Phase 2]